New Zealand Drug Foundation

Side Event: Working towards equitable access to treatment of problematic substance use for Indigenous peoples

Organized by Canada and New Zealand, and New Zealand Drug Foundation, Te Rau Ora Ltd and the Thunderbird Partnership Foundation. Michelle Boudreau, Health Canada: Welcome. Sincere thanks to organizers that did an tremendous amount work to prepare for this event. First Nations peoples experience extremely high levels violence and poverty and intergenerational trauma due to …

Read more

Item 11. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session (Afternoon session)

Indonesia: Nearly 3 years have passed since UNGASS – we have been committed to advancing promotion of human rights. In addressing the drug problems whilst protecting human rights the government has provided funding for therapy programmes for drug users and special needs populations such as women and children. It is important that human rights are …

Read more

Side Event: Civil society on member state delegations to the CND: Models for engagement, benefits, and lessons learned

Organised by the Governments of Canada, Mexico and New Zealand, the International Drug Policy Consortium, the Centre of Drug Policy Evaluation, the New Zealand Drug Foundation, and the Canadian Drug Policy Coalition Zara Snapp, Instituto RIA I’ve been on the Mexican delegation foe the last 6-7 years, and wanted to share experiences. Some delegations, you …

Read more

Plenary Session: Item 7. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session.

Canada – Canada is a strong supporter of the UNGASS outcome document and is committed to the implementation of its operational recommendations. The UNGASS outcome document not only represents the latest international consensus, but provides a balanced and comprehensive guide for our efforts to respond to the world drug problem. By incorporating key commitments from the …

Read more